MedTrace Logo

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness

NCT02105194 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-04-18

No results posted yet for this study

Summary

Chart review of patients who received hyperbaric oxygen therapy for cerebral decompression illness who also underwent SPECT brain blood flow imaging to see if SPECT brain imaging tracks and is consistent with the clinical condition of the patients.

Conditions

  • Cerebral Decompression Illness, All Phases

Interventions

DRUG

Hyperbaric oxygen therapy

total body exposure to greater than atmospheric pressure oxygen

Sponsors & Collaborators

  • Harch Hyperbaric Research Foundation

    collaborator OTHER

  • Paul G. Harch, M.D.

    lead OTHER

Principal Investigators

  • Paul G Harch, M.D. · LSU School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02105194 on ClinicalTrials.gov